Illinois lawmakers continue to push for more regulatory control of pharmacy benefit managers, or PBMs. PBMs act as third-party “middlemen” who negotiate the price pharmacies and insurance companies ...

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company ...

Q4 2024 Management View CEO Adam Steensberg emphasized 2024 as a transformational year for Zealand Pharma, highlighting significant clinical advancements in its obesity pipeline, particularly with ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...

Crews with The Salvation Army of Memphis and the Mid-South traveled to Kentucky this week to help out communities impacted by flooding due to heavy rainfall. Widespread ...

CRA International, Inc. ( NASDAQ: CRAI) Q4 2024 Earnings Conference Call February 20, 2025 10:00 AM ET Paul Maleh - Chairman, President, CEO Daniel Mahoney - EVP, CFO and Treasurer Chad Holmes - EVP ...

Letter to Trump describes threats to healthcare delivery with potentially limited access to drugs, medication ingredients and ...

StockNews.com downgraded shares of Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) from a strong-buy rating to a buy rating in a report issued on Wednesday. Aurinia Pharmaceuticals Price ...

Senate Study Bill 1051 would shield agricultural chemical companies like Bayer, which produces the glyphosate-based herbicide ...

Adjusted EPS of $0.92 topped estimates of $0.53. Revenue climbed to $747 million, beating the forecasted $712 million. Net ...